Hello, everyone, and how are you today? We are just fine, thank you, despite the miserable downpour that is turning the Pharmalot grounds into a soggy mess. Our short person successfully navigated the path to the local schoolhouse and our official mascots are resting comfortably in their corners. This leaves us to accomplish the task at hand, which is to forage for interesting items and pass along tidbits. And so, here they are. Hope your day is simply smashing and you conquer the world. Best of luck with that and do keep in touch …

The U.S. government is working to persuade other countries not to adopt recommendations made by the United Nations High-Level Panel on Access to Medicines, considering them to be ideologically driven and dangerous to economic growth, Intellectual Property Watch reports. The U.N. report, which was released in 2016, contains several proposals that have previously caused struggles with the pharmaceutical industry.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy